The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib/II study of oral nanatinostat (N) and valganciclovir (VG) in subjects with Epstein-Barr virus (EBV)-associated lymphomas.
 
Pierluigi Porcu
Honoraria - Actelion; Celgene
Consulting or Advisory Role - Innate Pharma
Research Funding - Celgene (Inst); Infinity Pharmaceuticals (Inst); Millennium (Inst); OncoMed (Inst); Seagen (Inst)
 
Bradley Haverkos
Consulting or Advisory Role - Viracta Therapeutics
 
Elizabeth Brem
Consulting or Advisory Role - Bayer; Celgene; Genentech; Janssen; Pfizer; Pharmacyclics
Speakers' Bureau - Celgene; Pharmacyclics
 
Anusha Vallurupalli
No Relationships to Disclose
 
Tatyana Feldman
Honoraria - Abbvie; Bayer; Bristol-Myers Squibb; Kite, a Gilead company; Pharmacyclics/Janssen; Seagen; Takeda
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Seagen
Speakers' Bureau - Abbvie; Celgene; Janssen; Kite, a Gilead company; Pharmacyclics; Seagen
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Cell Medica (Inst); Eisai (Inst); Kyowa Hakko Kirin (Inst); Kyowa Hakko Kirin (Inst); Pfizer (Inst); Portola Pharmaceuticals (Inst); Roche (Inst); Seagen (Inst); Trillium Therapeutics (Inst); Viracta Therapeutics (Inst); Viracta Therapeutics (Inst)
Travel, Accommodations, Expenses - Abbvie; Kite, a Gilead company; Pharmacyclics; Seagen; Takeda
 
Onder Alpdogan
Consulting or Advisory Role - Kyowa Hakko Kirin
Patents, Royalties, Other Intellectual Property - Patent sharing with Altor Bioscience Company
 
Jonathan Edward Brammer
Honoraria - Seagen
Research Funding - Celgene
 
Locke Johnson Bryan
No Relationships to Disclose
 
Stefan K. Barta
Consulting or Advisory Role - Janssen Oncology
Research Funding - Bayer (Inst); Celgene; Merck; Seagen; Takeda
Travel, Accommodations, Expenses - Curis
 
Sebastian Obrzut
Other Relationship - Viracta Therapeutics
 
Hao Shen
Consulting or Advisory Role - Viracta Therapeutics
Research Funding - Viracta Therapeutics; Viracta Therapeutics
 
Rosemary Rochford
Consulting or Advisory Role - Viracta Therapeutics
Research Funding - Viracta Therapeutics
 
Robert A. Baiocchi
Consulting or Advisory Role - Prelude Therapeutics; Viracta Therapeutics
Research Funding - Esanex; Prelude Therapeutics
 
Corey Casper
Consulting or Advisory Role - Curevo Vaccine; GlaxoSmithKline; Janssen; Temptime; Viracta Therapeutics
Research Funding - Janssen (Inst)
Patents, Royalties, Other Intellectual Property - Publication royalties from UpToDate
Travel, Accommodations, Expenses - GlaxoSmithKline; Temptime
 
John Gutheil
Employment - SciQuus Oncology
Leadership - SciQuus Oncology
Stock and Other Ownership Interests - SciQuus Oncology
Consulting or Advisory Role - Viracta Therapeutics (Inst)
 
Robert McRae
Employment - Clinical Trial and Consulting; Viracta Therapeutics
 
Preston Daniels
Employment - Viracta Therapeutics
Leadership - Viracta Therapeutics (I)
Stock and Other Ownership Interests - Viracta Therapeutics (I)
Patents, Royalties, Other Intellectual Property - Patent Pending
Travel, Accommodations, Expenses - Viracta Therapeutics (I)
 
Marshelle Smith Warren
Employment - Viracta Therapeutics
Leadership - Viracta Therapeutics
Stock and Other Ownership Interests - Viracta Therapeutics
Travel, Accommodations, Expenses - Viracta Therapeutics
 
Ivor Royston
Employment - Viracta Therapeutics
Leadership - Biocept
Stock and Other Ownership Interests - Biocept; Viracta Therapeutics
Patents, Royalties, Other Intellectual Property - Patents on immunooncology assigned to Viracta Therapeutics
 
Douglas V. Faller
Employment - Array BioPharma (I); Phoenicia Biosciences; Phoenicia Biosciences (I); Takeda
Leadership - Phoenicia Biosciences; Phoenicia Biosciences (I)
Stock and Other Ownership Interests - Array BioPharma (I); Briacell; Phoenicia Biosciences; Phoenicia Biosciences (I); Takeda; Viracta Therapeutics
Consulting or Advisory Role - Briacell; Takeda; Viracta Therapeutics
Patents, Royalties, Other Intellectual Property - Multiple issued patents as inventor relating to therapeutics for human diseases. Some licensed. Some assigned to my university.; Multiple issued patents as inventor relating to therapeutics for human diseases. Some licensed. Some assigned to university. (I)
Travel, Accommodations, Expenses - Phoenicia Biosciences; Phoenicia Biosciences (I)